| New This Week on Bioprocess Development Forum |
| |
- Can Vaccine Development Be Safely Accelerated?
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
(Read Article)
|
-
Manufacturing of Vaccines and Viral Vectors
With the pandemic outbreak of COVID-19, there is intense focus on developing a vaccine. However, the challenge not only lies in developing a vaccine but also in the ability to scale up the manufacturing process.
(Read Article)
|
- GE Expands Offering for ReadyToProcess™ Columns
ReadyToProcess™ columns are offered in seven inner diameters to meet the needs of upstream production.
(Read Article)
|
- The Future of Biopharma
Günter Jagschies, former Senior Director, Strategic Consumer Relations at GE Healthcare, highlights the evolution of the biopharma industry and Soon Jae Park, CEO of Alteogen, gives insights into challenges of establishing a biosimilars business in South Korea.
(Read Article)
|
| Bioprocess Development Forum Topic Spotlight |
| |
|
|
|
|
| |
GO TO: Bioprocess Development Forum
Join the Conversation on LinkedIn |
|
|
|
Questions for 2020
Like what you read? Want to see more of something in particular? Let us know what topics are on your mind and what you'd like to see more of in 2020. |
 |
|
|
